Structures by: Sen S.
Total: 180
C28.5H20ClNO2
C28.5H20ClNO2
Bioconjugate chemistry (2020)
a=11.6036(4)Å b=12.4468(4)Å c=14.8235(5)Å
α=83.0917(4)° β=83.3753(4)° γ=89.1925(4)°
C24H24N4Na2O17S2
C24H24N4Na2O17S2
Bioconjugate chemistry (2020)
a=7.8456(3)Å b=11.4365(4)Å c=17.3203(6)Å
α=85.3061(4)° β=88.1049(4)° γ=72.1013(4)°
C12H20NNaO10S
C12H20NNaO10S
Bioconjugate chemistry (2020)
a=7.2106(8)Å b=35.399(4)Å c=7.0277(8)Å
α=90° β=90° γ=90°
2-(4-methoxy-2,3-dimethylphenyl)-1H-benzo[d]imidazole, Water
C16H16N2O,0.5(H2O)
Organic letters (2016) 18, 13 3090-3093
a=12.441(4)Å b=8.216(2)Å c=26.040(7)Å
α=90° β=93.756(9)° γ=90°
C20H15N3O
C20H15N3O
The Analyst (2014) 139, 19 4828-4835
a=5.3994(12)Å b=14.277(4)Å c=20.499(5)Å
α=90° β=90° γ=90°
C20H15N3O
C20H15N3O
The Analyst (2014) 139, 19 4828-4835
a=5.3994(12)Å b=14.277(4)Å c=20.499(5)Å
α=90° β=90° γ=90°
C19H14N4
C19H14N4
The Analyst (2011) 136, 22 4839-4845
a=8.724(11)Å b=13.085(15)Å c=13.323(15)Å
α=90.00° β=97.447(10)° γ=90.00°
C18H13N3S
C18H13N3S
The Analyst (2012) 137, 14 3335-3342
a=8.3875(6)Å b=12.9511(8)Å c=13.3838(9)Å
α=90.00° β=98.248(6)° γ=90.00°
C16H13NO2
C16H13NO2
The Analyst (2012) 137, 17 3975-3981
a=9.7368(5)Å b=9.5514(4)Å c=13.8091(7)Å
α=90.00° β=107.501(5)° γ=90.00°
C16H13NO2
C16H13NO2
The Analyst (2012) 137, 17 3975-3981
a=9.7368(5)Å b=9.5514(4)Å c=13.8091(7)Å
α=90.00° β=107.501(5)° γ=90.00°
C21H18N2O3
C21H18N2O3
Organic letters (2011) 13, 17 4510-4513
a=6.6296(5)Å b=11.8971(9)Å c=23.4759(5)Å
α=90.00° β=90.00° γ=90.00°
1-benzyl-3-((2-(2-nitrobenzoyl)-1H-indol-3-yl)methyl)piperazine-2,5-dione
C27H22N4O5
Org. Biomol. Chem. (2017)
a=13.2852(18)Å b=6.7684(10)Å c=14.0755(19)Å
α=90° β=112.709(4)° γ=90°
Methyl 1-(2-nitrophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
C19H17N3O4
Org. Biomol. Chem. (2017)
a=8.962(3)Å b=9.634(5)Å c=20.046(11)Å
α=90° β=90° γ=90°
(Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=7.303(3)Å b=16.637(5)Å c=12.598(5)Å
α=90° β=97.725(13)° γ=90°
(Z)-2-(piperidin-1-yl)-5-(2,4,5-trimethoxybenzylidene)thiazol-4(5H)-one
C18H22N2O4S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=10.0466(4)Å b=7.7834(3)Å c=22.9774(10)Å
α=90° β=93.920(2)° γ=90°
(Z)-5-(4-(dimethylamino)benzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C17H21N3OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=12.7194(4)Å b=8.0294(3)Å c=16.4422(6)Å
α=90° β=105.3040(10)° γ=90°
(Z)-5-(4-methoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=8.5748(3)Å b=16.5115(5)Å c=10.8532(4)Å
α=90° β=100.9220(10)° γ=90°
(Z)-5-(4-methoxy-2,3-dimethylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C18H22N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=13.1879(8)Å b=8.2959(4)Å c=16.8693(10)Å
α=90° β=111.933(2)° γ=90°
(Z)-2-(piperidin-1-yl)-5-(4-propoxybenzylidene)thiazol-4(5H)-one
C18H22N2O2S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=14.6019(6)Å b=15.8336(5)Å c=7.5085(3)Å
α=90° β=90.141(2)° γ=90°
(Z)-5-(2-methylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=19.808(2)Å b=19.648(2)Å c=7.5797(8)Å
α=90° β=95.378(4)° γ=90°
(Z)-5-(2,3-dimethoxybenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C17H20N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=6.9066(6)Å b=10.3537(10)Å c=12.5514(13)Å
α=96.955(4)° β=103.338(3)° γ=100.576(3)°
(Z)-5-(naphthalen-1-ylmethylene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C19H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=19.3839(6)Å b=7.7880(3)Å c=20.9133(8)Å
α=90° β=90° γ=90°
(Z)-5-(benzo[d][1,3]dioxol-4-ylmethylene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H16N2O3S
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=8.3333(6)Å b=16.8148(12)Å c=10.7927(8)Å
α=90° β=103.960(2)° γ=90°
C20H17N3O8
C20H17N3O8
Organic & biomolecular chemistry (2011) 9, 2 358-360
a=9.7745(6)Å b=9.7915(4)Å c=20.5118(9)Å
α=90.00° β=90.00° γ=90.00°
C60H70AuN6O6,F6P
C60H70AuN6O6,F6P
Chemical communications (Cambridge, England) (2020) 56, 57 7877-7880
a=10.8241(6)Å b=18.2147(9)Å c=32.3647(17)Å
α=102.209(4)° β=97.728(4)° γ=104.498(5)°
C52H60AuN4O3,F6P
C52H60AuN4O3,F6P
Chemical communications (Cambridge, England) (2020) 56, 57 7877-7880
a=16.47860(10)Å b=22.15860(10)Å c=27.4653(2)Å
α=90° β=90° γ=90°
C50H62AuN4O3,F6P
C50H62AuN4O3,F6P
Chemical communications (Cambridge, England) (2020) 56, 57 7877-7880
a=17.129(4)Å b=14.925(3)Å c=19.946(4)Å
α=90° β=107.130(5)° γ=90°
C27H36N2,C14H18N2O,Au1,PF61
C27H36N2,C14H18N2O,Au1,PF61
Chemical Communications (2019)
a=11.5799(13)Å b=12.395(2)Å c=15.448Å
α=90.340(7)° β=110.629(8)° γ=92.601(7)°
C32H29N3O2,C27H36N2,Au1,PF61
C32H29N3O2,C27H36N2,Au1,PF61
Chemical Communications (2019)
a=11.0376(11)Å b=22.224(2)Å c=12.1752(14)Å
α=90° β=94.2560(10)° γ=90°
C27H36N2,C21H21N3O5,Au1,PF61
C27H36N2,C21H21N3O5,Au1,PF61
Chemical Communications (2019)
a=10.6871(4)Å b=15.3640(6)Å c=16.2640(5)Å
α=110.760(3)° β=92.833(3)° γ=99.200(3)°
C15H17N4O2,C27H36N2,Au1,PF61
C15H17N4O2,C27H36N2,Au1,PF61
Chemical Communications (2019)
a=11.0823(2)Å b=17.7057(4)Å c=24.2599(4)Å
α=70.377(2)° β=88.2690(10)° γ=79.328(2)°
C27H36N2,C22H25N3O2,Au,0.25CH2Cl2
C27H36N2,C22H25N3O2,Au,0.25CH2Cl2
Chemical Communications (2019)
a=11.1145(6)Å b=18.0534(9)Å c=25.6124(14)Å
α=83.682(4)° β=84.131(5)° γ=78.693(5)°
C27H36N2,C19H25N3O3,Au1,PF61
C27H36N2,C19H25N3O3,Au1,PF61
Chemical Communications (2019)
a=11.0059(5)Å b=18.0147(9)Å c=25.0303(7)Å
α=100.792(3)° β=96.933(3)° γ=99.946(4)°
C27H36N2,C25H31N3O2,Au1,PF61,1/2H2O
C27H36N2,C25H31N3O2,Au1,PF61,1/2H2O
Chemical Communications (2019)
a=43.9057(11)Å b=11.3191(4)Å c=47.4794(9)Å
α=90° β=90° γ=90°
None
C20H15F3NOP
Chemical Communications (2017)
a=9.050(2)Å b=10.383(3)Å c=10.614(3)Å
α=104.413(3)° β=108.914(2)° γ=98.323(2)°
None
C40H30AuClF6N2O2P2
Chemical Communications (2017)
a=8.3163(18)Å b=11.311(2)Å c=20.388(4)Å
α=97.177(3)° β=92.474(3)° γ=90.001(3)°
None
0.5(C40H30Au2Cl2F6N2O2P2)
Chemical Communications (2017)
a=12.419(3)Å b=19.253(4)Å c=17.779(4)Å
α=90° β=108.598(2)° γ=90°
Indozolidinoindolones
C16H18N2O2
New J. Chem. (2015) 39, 12 9281
a=9.735(3)Å b=11.144(3)Å c=12.745(4)Å
α=90° β=90° γ=90°
Indozolidinoindolones
C16H18N2O2
New J. Chem. (2015) 39, 12 9281
a=9.821(8)Å b=11.174(8)Å c=12.954(10)Å
α=90° β=90° γ=90°
Spiroindolopyrrolizinones
C15H16N2O2
New J. Chem. (2015) 39, 12 9281
a=7.289(3)Å b=11.525(4)Å c=14.616(5)Å
α=90° β=91.587(19)° γ=90°
C30H33N3
C30H33N3
New J. Chem. (2015) 39, 2 886
a=13.508(9)Å b=24.193(16)Å c=7.507(5)Å
α=90.00° β=94.8640(10)° γ=90.00°
C48H42N12O21
C48H42N12O21
New J. Chem. (2015) 39, 2 886
a=10.766(3)Å b=13.960(5)Å c=17.294(6)Å
α=102.357(5)° β=98.189(5)° γ=100.935(4)°
(4aR*,8aS*,9aR*,10aS*)-1,4,4a,5,8,8a,9,9a,10,10a-decahydro- 4a,8a,9a,10a-anthracenetetraol
C14H20O4
CrystEngComm (2005) 7, 65 398
a=6.7802(9)Å b=6.7802(9)Å c=27.425(7)Å
α=90° β=90° γ=90°
(4aR,8aS,9aR,10aS)perhydro-4a,8a,9a,10a-anthracenetetraol
C14H24O4
CrystEngComm (2005) 7, 65 398
a=5.958(5)Å b=5.994(5)Å c=9.867(8)Å
α=86.177(13)° β=82.547(13)° γ=73.200(12)°
(4aR*,8aS*,9aR*,10aS*)-1,4,4a,5,8,8a,9,9a,10,10a-decahydro- 4a,8a,9a,10a-anthracenetetraol
C14H20O4
CrystEngComm (2005) 7, 65 398
a=9.2811(19)Å b=9.926(2)Å c=13.927(3)Å
α=92.912(3)° β=101.065(3)° γ=91.848(4)°
C27H25FN2O6
C27H25FN2O6
RSC Advances (2013) 3, 7 2404
a=6.3422(10)Å b=9.6502(5)Å c=40.630(4)Å
α=90.00° β=90.00° γ=90.00°
(3aR*,4R*,5S*,6R*,7S*,7aR*)perhydro-3a,4,5,6,7,7a-indenehexaol
C9H16O6
CrystEngComm (2005) 7, 109 656
a=7.746(4)Å b=10.408(5)Å c=12.556(7)Å
α=90° β=100.061(8)° γ=90°
Annulated myo-inositol
C10H18O6
CrystEngComm (2005) 7, 109 656
a=6.1134(13)Å b=7.6139(13)Å c=11.668(2)Å
α=102.319(3)° β=97.916(3)° γ=91.829(2)°
Annulated chiro-inositol
C10H18O6
CrystEngComm (2005) 7, 109 656
a=12.559(4)Å b=12.916(4)Å c=13.860(4)Å
α=87.959(6)° β=87.627(6)° γ=70.606(6)°
C19H9N2O10Zn2
C19H9N2O10Zn2
Chemical communications (Cambridge, England) (2015) 51, 15 3173-3176
a=17.7349(6)Å b=17.7349(6)Å c=28.1732(10)Å
α=90.00° β=90.00° γ=90.00°
C19H9N2O10Zn2
C19H9N2O10Zn2
Chemical communications (Cambridge, England) (2015) 51, 15 3173-3176
a=25.4440(14)Å b=25.4440(14)Å c=53.616(3)Å
α=90.00° β=90.00° γ=90.00°
C19H9N2O10Zn2
C19H9N2O10Zn2
Chemical communications (Cambridge, England) (2015) 51, 15 3173-3176
a=25.5552(11)Å b=25.5552(11)Å c=51.403(2)Å
α=90.00° β=90.00° γ=90.00°
C19H9Cu2N2O10
C19H9Cu2N2O10
Chemical communications (Cambridge, England) (2015) 51, 15 3173-3176
a=17.7179(7)Å b=17.7179(7)Å c=27.5566(13)Å
α=90.00° β=90.00° γ=90.00°
C19H9Cu2N2O10
C19H9Cu2N2O10
Chemical communications (Cambridge, England) (2015) 51, 15 3173-3176
a=25.4117(14)Å b=25.4117(14)Å c=52.162(6)Å
α=90.00° β=90.00° γ=90.00°
(6-ammoniohexyl)ammonium bislithocholate
2(C24H39O3),C6H18N2
Journal of Materials Chemistry (2009) 19, 25 4325
a=19.292(8)Å b=7.694(3)Å c=19.957(8)Å
α=90° β=117.454(7)° γ=90°
All trans-perhydro-2,3,4a,6,7,8a-naphthalenehexaol
C10H18O6
CrystEngComm (2007) 9, 2 144
a=6.5273(14)Å b=5.9589(12)Å c=13.166(3)Å
α=90° β=90.163(3)° γ=90°
All trans-perhydro-2,3,4a,6,7,8a-naphthalenehexaol monohydrate
C10H18O6,H2O
CrystEngComm (2007) 9, 2 144
a=6.663(2)Å b=9.045(3)Å c=10.707(3)Å
α=72.385(5)° β=81.655(5)° γ=69.238(5)°
(3aR*,4R*,9R*,9aS*)-9-(hydroxymethyl)-2,2-dimethyl-3a,4,9,9a- tetrahydrocycloocta(d)(1,3)dioxol-4-ol
C12H18O4
CrystEngComm (2008) 10, 5 534
a=7.894(2)Å b=21.662(6)Å c=7.747(2)Å
α=90° β=115.645(4)° γ=90°
(3aS*,4S*,9S*,9aR*)-9-(hydroxymethyl)-2,2-dimethyl- 3a,4,7,8,9,9a-hexahydro-cycloocta(d)(1,3)dioxol-4-ol
C12H20O4
CrystEngComm (2008) 10, 5 534
a=8.8996(16)Å b=14.342(3)Å c=19.650(4)Å
α=90.00° β=102.262(3)° γ=90.00°
C68H56.50Co2N8O8,0.25(H2O)
C68H56.50Co2N8O8,0.25(H2O)
Dalton Transactions (2008) 13 1783-1786
a=15.2810(13)Å b=19.1585(17)Å c=21.3594(16)Å
α=90.00° β=104.784(4)° γ=90.00°
Compound 1
C25H36N5O4S1ZN1,C17H20N5O4S3Zn2
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=10.5391(16)Å b=14.630(2)Å c=17.946(3)Å
α=101.851(2)° β=94.654(3)° γ=104.704(2)°
Compound 3
C26H34Cd2N6O4S2
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=14.590(5)Å b=15.638(5)Å c=14.792(5)Å
α=90° β=103.911(5)° γ=90°
Compound 4
2(C25H36CoN5O4S),C4CoN4S4
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=14.227(18)Å b=19.468(20)Å c=13.857(18)Å
α=104.05(9)° β=93.52(11)° γ=109.48(8)°
C25H36CoN5O4S,ClO4
C25H36CoN5O4S,ClO4
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=9.229(4)Å b=29.702(4)Å c=10.646(2)Å
α=90° β=96.75(2)° γ=90°
Compound 7
C26H44MnN4O6,3(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=27.105(7)Å b=15.978(4)Å c=8.482(2)Å
α=90.00° β=96.566(13)° γ=90.00°
Compound 6
C20H24CoN5O5,0.5(CH4O)
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=10.031(3)Å b=10.612(2)Å c=20.996(3)Å
α=94.152(15)° β=80.05(2)° γ=84.45(2)°
Compound 1
C30H28Cu2N8O4,2(ClO4)
Dalton Transactions (2009) 34 6849-6860
a=8.141(2)Å b=12.2329(17)Å c=17.302(3)Å
α=90.00° β=95.719(18)° γ=90.00°
Compound 2
C36H28Cl2Cu2N8O10
Dalton Transactions (2009) 34 6849-6860
a=12.3678(12)Å b=12.8964(11)Å c=12.9157(12)Å
α=90.00° β=115.200(9)° γ=90.00°
Compound 4
C46H40Cu2N6O4
Dalton Transactions (2009) 34 6849-6860
a=20.978(2)Å b=15.6254(15)Å c=24.649(3)Å
α=90.00° β=90.00° γ=90.00°
Compound 3
C38H34Cu2N6O4,2(ClO4)
Dalton Transactions (2009) 34 6849-6860
a=15.0479(16)Å b=16.0303(17)Å c=19.1499(19)Å
α=72.222(2)° β=89.242(2)° γ=65.772(2)°
C20H14ClCuN3O
C20H14ClCuN3O
RSC Adv. (2015)
a=8.06690(10)Å b=10.2015(2)Å c=10.8792(2)Å
α=90.4250(10)° β=104.9720(10)° γ=94.3570(10)°
C24H20N4O8
C24H20N4O8
RSC Adv. (2015)
a=14.7508(11)Å b=9.8446(8)Å c=13.9881(8)Å
α=90° β=91.028(3)° γ=90°
Pf17
C13H8BrNO3S,C5H9NO
RSC Adv. (2015)
a=7.4930(4)Å b=32.9156(16)Å c=7.6917(4)Å
α=90° β=104.704(2)° γ=90°
(Z)-5-(4-methylbenzylidene)-2-(piperidin-1-yl)thiazol-4(5H)-one
C16H18N2OS
Organic & biomolecular chemistry (2016) 14, 34 8053-8063
a=12.5012(6)Å b=16.1346(7)Å c=7.6541(4)Å
α=90° β=106.967(2)° γ=90°
Compound 2
C24H34Cd2Cl2N4O4
Dalton transactions (Cambridge, England : 2003) (2006) 14 1758-1767
a=15.373(8)Å b=14.399(7)Å c=14.621(9)Å
α=90.00° β=112.94(4)° γ=90.00°
(1r,2R,6S,8r,10R,14S)-5,7,9,11- tetraoxatetracyclo[6.6.0.0^2,6^.0^10,14^]tetradecane
C10H14O4
RSC Adv. (2015) 5, 87 70899
a=10.420(5)Å b=5.899(3)Å c=15.377(8)Å
α=90° β=94.096(7)° γ=90°
(1R,2R,6R,8S,10R,14S)-5,7,9,11- tetraoxatetracyclo[6.6.0.0^{2,6}.0^{10,14}] tetradecan-4- one
C10H12O5
RSC Adv. (2015) 5, 87 70899
a=6.0046(6)Å b=6.0046(6)Å c=45.980(6)Å
α=90° β=90° γ=120°
C33H21F6N6O4PRu
C33H21F6N6O4PRu
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4373-4381
a=8.5554(3)Å b=14.010Å c=14.658Å
α=68.476(11)° β=75.226(14)° γ=77.465(15)°
C33H24BF10N6OPRu
C33H24BF10N6OPRu
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4373-4381
a=16.9299(4)Å b=16.5148(3)Å c=11.3820(3)Å
α=90° β=100.740(2)° γ=90°
C33H21ClN6O6.5Ru
C33H21ClN6O6.5Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4373-4381
a=8.4666(11)Å b=11.6275(14)Å c=16.1049(19)Å
α=90.226(5)° β=98.860(8)° γ=97.136(7)°
C33H22F12N6OP2Ru
C33H22F12N6OP2Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4373-4381
a=11.4581(5)Å b=32.7007(12)Å c=21.7230(11)Å
α=90° β=93.480(5)° γ=90°
C38H38Co2N4O6.H2O
C38H38Co2N4O6.H2O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 8 1652-1661
a=10.035(3)Å b=13.078(4)Å c=14.492(5)Å
α=90.443(14)° β=100.661(12)° γ=105.340(11)°
C40H52N4Ni4O12
C40H52N4Ni4O12
Dalton transactions (Cambridge, England : 2003) (2011) 40, 8 1652-1661
a=10.347(5)Å b=9.598(4)Å c=22.172(11)Å
α=90.00° β=90.676(15)° γ=90.00°
C40H48Co4N5O131,(NO31),2(H2O)
C40H48Co4N5O131,(NO31),2(H2O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 8 1652-1661
a=11.983(3)Å b=13.084(3)Å c=16.634(4)Å
α=86.68(2)° β=88.72(3)° γ=65.55(2)°
C78H75N5O3,2(CH2Cl2)
C78H75N5O3,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 3 726-734
a=11.970(5)Å b=13.569(5)Å c=21.610(5)Å
α=74.456(5)° β=87.681(5)° γ=84.415(5)°
Mercuryarenide
C72H144As14Hg2K4N8O24
Dalton transactions (Cambridge, England : 2003) (2012) 41, 18 5454-5457
a=14.029(3)Å b=21.253(5)Å c=43.060(10)Å
α=90.00° β=90.00° γ=90.00°
C29H18N6O8Zn
C29H18N6O8Zn
Dalton transactions (Cambridge, England : 2003) (2014) 43, 16 6100-6107
a=10.3954(6)Å b=12.7503(7)Å c=14.0871(9)Å
α=63.3380(10)° β=89.9780(10)° γ=86.0050(10)°
C39H34N4O10Zn2
C39H34N4O10Zn2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 16 6100-6107
a=18.9292(16)Å b=24.320(2)Å c=9.6354(8)Å
α=90.00° β=90.00° γ=90.00°
Arsenidecluster
2(C18H36KN2O6),C4H8O,As7
Chem.Commun. (2011) 47, 3126
a=10.862(3)Å b=12.933(4)Å c=21.592(6)Å
α=102.376(5)° β=96.120(6)° γ=100.964(5)°
(all trans)-3,6,7-tri(acetyloxy)-4a,8a-dihydroxyperhydro-2-naphthalenyl acetate
C18H26O10
Chemical communications (Cambridge, England) (2009) 40 5981-5983
a=21.433(7)Å b=5.7126(18)Å c=16.720(5)Å
α=90° β=105.664(5)° γ=90°
(all trans)-3,6,7-tri(acetyloxy)-4a,8a-dihydroxyperhydro-2-naphthalenyl acetate
C18H26O10
Chemical communications (Cambridge, England) (2009) 40 5981-5983
a=19.991(5)Å b=6.0024(15)Å c=16.225(4)Å
α=90° β=91.130(4)° γ=90°
(all trans)-3,6,7-tri(acetyloxy)-4a,8a-dihydroxyperhydro-2-naphthalenyl acetate
C18H26O10
Chemical communications (Cambridge, England) (2009) 40 5981-5983
a=19.430(4)Å b=6.0815(13)Å c=15.994(3)Å
α=90° β=91.849(4)° γ=90°
C34H26Ag2N8,2(C2F6NO4S2),CH2Cl2
C34H26Ag2N8,2(C2F6NO4S2),CH2Cl2
CrystEngComm / RSC (2013) 2013, 21 4221-4224
a=13.259(2)Å b=23.277(4)Å c=16.617(3)Å
α=90° β=110.187(3)° γ=90°
C44H32Ag3N10,3(C2F6NO4S2)
C44H32Ag3N10,3(C2F6NO4S2)
CrystEngComm / RSC (2013) 2013, 21 4221-4224
a=12.850(2)Å b=14.293(3)Å c=18.304(3)Å
α=77.112(3)° β=85.209(3)° γ=69.054(3)°
C56H42Ag4N14,4(C2F6NO4S2)
C56H42Ag4N14,4(C2F6NO4S2)
CrystEngComm / RSC (2013) 2013, 21 4221-4224
a=18.8120(19)Å b=22.261(2)Å c=20.920(2)Å
α=90° β=110.691(2)° γ=90°
C19H14AgN4,C2N,C2F6NO4S2
C19H14AgN4,C2N,C2F6NO4S2
CrystEngComm / RSC (2013) 2013, 21 4221-4224
a=20.635(7)Å b=22.481(7)Å c=13.652(5)Å
α=90° β=124.337(9)° γ=90°
C33H68Cl3N5O13
C33H68Cl3N5O13
CrystEngComm (2010) 12, 10 2967
a=13.079(5)Å b=14.156(4)Å c=14.444(4)Å
α=107.729(5)° β=98.846(4)° γ=116.684(6)°
C33H57Cl4N5O23
C33H57Cl4N5O23
CrystEngComm (2010) 12, 10 2967
a=15.007(5)Å b=14.443(3)Å c=21.342(6)Å
α=90.00° β=95.480(5)° γ=90.00°
C33H61Cl2N5O13S
C33H61Cl2N5O13S
CrystEngComm (2010) 12, 10 2967
a=9.465(4)Å b=26.756(6)Å c=16.270(5)Å
α=90.00° β=93.333(6)° γ=90.00°
C33H57Cl4N5O23
C33H57Cl4N5O23
CrystEngComm (2010) 12, 10 2967
a=13.327(5)Å b=12.267(3)Å c=28.121(6)Å
α=90.00° β=103.374(6)° γ=90.00°